These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28647939)

  • 1. Non-Criteria or Seronegative Obstetric Antiphospholipid Syndrome?
    Jara LJ; Medina G; Cruz-Cruz P; Olivares-Rivera J; Duarte-Salazar C; Saavedra MA
    Isr Med Assoc J; 2017 Jun; 19(6):382-386. PubMed ID: 28647939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice.
    Yang Y; Jiang H; Tang Z; Pan H; Liu H; Cheng X; Su Y; Ye J; Hu Q; Meng J; Chi H; Zhou Z; Jia J; Yang C; Shi H; Teng J; Liu T
    J Autoimmun; 2024 Jun; 146():103237. PubMed ID: 38749076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis.
    Santos TDS; Ieque AL; de Carvalho HC; Sell AM; Lonardoni MVC; Demarchi IG; de Lima Neto QA; Teixeira JJV
    J Reprod Immunol; 2017 Sep; 123():78-87. PubMed ID: 28985591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world practice of obstetricians in respect of assays for antiphospholipid antibodies.
    Sugiura-Ogasawara M; Atsumi T; Yamada H; Kitaori T; Ozaki Y; Katano K; Murashima A
    Mod Rheumatol; 2015; 25(6):883-7. PubMed ID: 25736360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-beta2-glycoprotein I antibodies--when and how should they be measured?
    Reber G; de Moerloose P
    Thromb Res; 2004; 114(5-6):527-31. PubMed ID: 15507287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease.
    Palomo I; Segovia F; Ortega C; Pierangeli S
    Clin Exp Rheumatol; 2009; 27(4):668-77. PubMed ID: 19772805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis and management challenges in the antiphospholipid syndrome.
    Bertolaccini ML; Khamashta MA
    Lupus; 2006; 15(3):172-8. PubMed ID: 16634372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiphospholipid syndrome].
    Atsumi T; Koike T
    Nihon Rinsho; 1998 Jan; 56(1):215-23. PubMed ID: 9465693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibody syndrome and fetal outcome.
    Djelmis J; Radoncić E; Ivanisević M
    Acta Med Croatica; 2001; 55(3):123-30. PubMed ID: 11852731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.